Impact of low-grade adverse events on health-related quality of life in adult patients receiving imatinib or nilotinib for newly diagnosed Philadelphia chromosome positive chronic myelogenous leukemia in chronic phase-Reference-Cited by-同舟云学术

Impact of low-grade adverse events on health-related quality of life in adult patients receiving imatinib or nilotinib for newly diagnosed Philadelphia chromosome positive chronic myelogenous leukemia in chronic phase

Published:2014-08-05 Issue:11 Volume:30 Page:2317-2328
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Guérin Annie¹,Chen Lei²,Ionescu-Ittu Raluca¹,Marynchenko Maryna³,Nitulescu Roy¹,Hiscock Robert¹,Keir Christopher²,Wu Eric Qiong³

Affiliation:

1. Analysis Group Inc. Montreal, QCCanada

2. Novartis Pharmaceuticals Corporation East Hanover, NJUSA

3. Analysis Group Inc. Boston, MAUSA

Publisher

Informa Healthcare

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1185/03007995.2014.944973

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Cost-effectiveness of systematic chemotherapy for metastatic pancreatic cancer: a retrospective study using Japanese clinical data;2024-05-10

3. Successful maintenance of a sustained molecular response in CML patients receiving low-dose tyrosine kinase inhibitors;Therapeutic Advances in Hematology;2024-01

4. Chronic myeloid leukaemia: A qualitative interview study exploring disease impact from patient and practitioner perspectives;European Journal of Oncology Nursing;2023-12

5. Chronic Myeloid Leukaemia: A Qualitative Study of Patient and Practitioner Experiences of Managing Treatment;European Journal of Cancer Care;2023-11-25